Home › Amyloidosis › Oregon
Pag-aaral pangklinika para sa Amyloidosis sa Oregon
6 pag-aaral para sa Amyloidosis ang naghahanap ng mga kalahok sa mga site sa Oregon.
Mga Lungsod sa Oregon
Opisyal na teksto ng pag-aaral (English)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Portland
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Portland
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07052903Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Oregon Health & Science University, Portland
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06563895A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Oregon Medical Research Center /ID# 255119, Portland
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update May 13, 2026 · NCT06158854Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
- Oregon Health & Science University, Portland
Nagre-recruitPhase 2
Edad 40 hanggang 90 · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT05758493MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Oregon Health and Science University (OHSU), Portland
Nagre-recruitPhase 3
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06128629Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.